Please login to the form below

Not currently logged in

Merck & Co halts development of potential COVID-19 drug MK-7110

Merck & Co HQ

Pharma company has abandoned drug due to technical, clinical and regulatory uncertainties

GSK discontinues two feladilimab trials in head and neck cancer

GSK - logo on buildingDecision made after recommendation from Independent Data Monitoring Committee

BeiGene, Novartis’s PD-1 inhibitor tislelizumab hits the mark in second- or third-line NSCLC

BeigenePD-1 inhibitor improved overall survival compared to chemotherapy medication docetaxel

UK trial evaluating mixed-vaccine regimens includes two more jabs

COVID-19 vaccineResults from the first stage of the Com-Cov trial are expected next month

Moderna’s booster vaccine for South African variant demonstrates promising early results

Booster vaccine candidate increase neutralising titers against SARS-CoV-2 variants of concern in preclinical study

Lilly’s RET inhibitor Retevmo shows early promise in new cancer types

Eli Lilly new HQTrial included patients with pancreatic, colon, breast and salivary cancer

Oxford study finds standard asthma medication improves recovery time in COVID-19 patients

Coronavirus newEarly treatment with inhaled budesonide could help high-risk patients

Opdivo improves survival in oesophageal cancer

BMS buildingBMS releases new data from its phase 3 CHECKMATE-648 study

Opdivo plus chemotherapy increases response in pre-surgery NSCLC patients

BMS buildingCombination increases complete response rate to 24% compared to chemotherapy alone

clusterAdopting a creative IP approach towards biotech clusters

Why big pharma paradigm needs to change

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...